Importantly, elimination of Akt prevented proliferative heterogeneity in these lines in cell culture (Dey-Guha et al., 2015), and inhibition of asymmetric Akt signaling reduced tumor recurrence after treatment in a xenograft model (Alves et al., 2018). This evidence concerns the gene AKT1 and neoplasm.